Prognostic Value of CTA-Derived Left Ventricular Mass in Neonates with Congenital Heart Disease

Stephan Ellmann1, Julie-Marie Nickel1, Rafael Heiss1,2

  • 1Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany.

Insights

Left ventricular mass (LVM) in infants with congenital heart disease (CHD) is measurable via CT angiography. Lower LVM in hypoplastic left heart patients indicates surgical repair needs, aiding therapeutic decisions.

Area of Science:

  • Pediatric Cardiology
  • Medical Imaging
  • Congenital Heart Disease Research

Background:

  • Left ventricular mass (LVM) is crucial for surgical repair decisions in congenital heart disease (CHD).
  • Accurate LVM assessment in infants with CHD is vital for guiding therapeutic strategies.

Purpose of the Study:

  • To determine LVM in infants with CHD using thoracic computed tomography angiographies (CTAs).
  • To evaluate LVM's prognostic value, particularly in hypoplastic left heart (HLH) patients.
  • To establish an LVM cutoff for differentiating uni- vs. biventricular surgical repair.

Main Methods:

  • Retrospective analysis of 132 infants' CTAs.
  • Manual segmentation of left ventricular volumes to calculate LVM, normalized to body surface area.
  • Statistical analyses including ANOVA, ROC curves, and Kaplan-Meier survival analysis.

Main Results:

  • Significantly lower mean LVM in HLH patients (21.88 g/m²) compared to non-HLH CHD patients (50.22 g/m²).
  • An LVM cutoff of 33.9 g/m² effectively discriminated between uni- and biventricular repair strategies.
  • LVM demonstrated prognostic value in HLH patients, with high specificity and PPV.

Conclusions:

  • LVM can be reliably measured in newborns with CHD via chest CTA.
  • LVM serves as a valuable prognostic indicator for therapeutic decisions in pediatric CHD.
  • This non-invasive measurement aids in selecting appropriate surgical approaches for complex heart conditions.